About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
https://www.weizmann-usa.org/news-media/in-the-news/abbott-labs-seeks-the-next-best-thing-in-israel/
Mar 13, 2012... Dr. Dieter Ziegler, Abbott's global external research director for Europe, with Prof. Irit Sagi, a metalloenzyme researcher from the Weizmann Institute of Scien ... Read more
Jul 03, 2013... Israel has provided the global drug development pipeline with many well–known internationally successful medications including Copaxone, Rebif, Exelon, Doxil, ... Read more
Oct 11, 2011...
October is National Breast Cancer Awareness Month
October is National Breast Cancer Awareness Month, bringing critical attention to what is today the most ... Read more
https://www.weizmann-usa.org/news-media/feature-stories/november-is-american-diabetes-month/
Nov 01, 2017... As we enter a time of year abundant with food-centric holidays and gatherings, it can be helpful to pause for a moment to think about how we eat – and how much. ... Read more
https://www.weizmann-usa.org/news-media/in-the-news/my-intuition-says-teva-will-get-out-of-this/
Oct 09, 2017...
Prof. Michael Sela Photo: Eyal Izhar
“My intuition tells me that Teva will extricate itself,” Professor Michael Sela, who, together with Ruth Arnon and Deb ... Read more
https://www.weizmann-usa.org/news-media/video-gallery/best-people-best-science/
Jul 06, 2016... The Weizmann Institute's most important asset is its people. That's why the Institute is committed to recruiting and nurturing some of the world's brightest you ... Read more
https://www.weizmann-usa.org/news-media/in-the-news/bacteria-alert-by-scientist/
Dec 01, 2017... The Israeli crystallographer, who shared the chemistry Nobel with Venkatraman Ramakrishnan and Thomas A. Steitz in 2009 for her work on ribosome, was delivering ... Read more
Dec 20, 2011... Teva Pharmaceutical Industries Ltd., the world’s largest generic-drug maker, is seeking to transform a compound once rejected by Sanofi into the first treatment ... Read more
Mar 20, 2019... Yeda CEO Gil Granot-Mayer (left to right) BioLeaders CEO, Dr. Young-Chul Park and Weizmann Institute Vice President for Technology Transfer Prof. Mordechai Shev ... Read more
Oct 11, 2011... “I believe there is real magic in the way thatembryos develop. I’ve been studying them for almost 15 years and Ihaven’t stopped being amazed,” says Dr. Karina Y ... Read more
©2024 American Committee for the Weizmann Institute of Science
